Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China

Vikalp Kumar Maheshwari; Cassandra Slader; Nidhi Dani; Christina Gkitzia; Quan Yuan; Tengbin Xiong; Yu Liu; Ricardo Viana

doi:10.1371/journal.pone.0259076

Loading metrics

Open Access

Peer-reviewed

Research Article

Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China

Vikalp Kumar Maheshwari,

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – review & editing

Affiliation NBS CONEXTS–Value & Access, Novartis Healthcare Pvt. Ltd., Hyderabad, Telangana, India
⨯
Cassandra Slader,

Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Writing – review & editing

Affiliation Novartis Pharma AG, Medical Affairs, Basel, Basel Stadt, Switzerland
⨯
Nidhi Dani,

Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Writing – review & editing

Affiliation Novartis Pharma AG, Value & Access, Basel, Basel Stadt, Switzerland
⨯
Christina Gkitzia,

Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Writing – review & editing

Affiliation Novartis Pharma AG, Value & Access, Basel, Basel Stadt, Switzerland
⨯
Quan Yuan,

Roles Data curation, Writing – review & editing

Affiliation Novartis Oncology, Market Access Strategy, Beijing, China
⨯
Tengbin Xiong,

Roles Data curation, Writing – review & editing

Affiliation Novartis Oncology, Novartis Campus, Shanghai, China
⨯
Yu Liu,

Roles Data curation, Writing – review & editing

Affiliation Novartis Oncology, Medical Affairs, Beijing, China
⨯
Ricardo Viana

Roles Conceptualization, Funding acquisition, Investigation, Project administration, Resources, Supervision, Validation, Writing – review & editing

* E-mail: Ricardo.Viana@novartis.com

Affiliation Novartis Pharma AG, Global Value & Access, Oncology, Basel, Basel Stadt, Switzerland

https://orcid.org/0000-0001-9261-6942

⨯

Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China

Vikalp Kumar Maheshwari,
Cassandra Slader,
Nidhi Dani,
Christina Gkitzia,
Quan Yuan,
Tengbin Xiong,
Yu Liu,
Ricardo Viana

Published: October 25, 2021
https://doi.org/10.1371/journal.pone.0259076

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Chinese people
Is the Subject Area "Chinese people" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
Chronic myeloid leukemia
Is the Subject Area "Chronic myeloid leukemia" applicable to this article?

Thanks for your feedback.
Blood transfusion
Is the Subject Area "Blood transfusion" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Interferons
Is the Subject Area "Interferons" applicable to this article?

Thanks for your feedback.
Treatment guidelines
Is the Subject Area "Treatment guidelines" applicable to this article?

Thanks for your feedback.